Warning: Invalid argument supplied for foreach() in
/home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line
21
2017.12.22
Acute SCI Phase I/II completed PDF
Kringle Pharma announces completion of participant enrollment in the Phase I/II study of recombinant human HGF for acute spinal cord injury.
